iBio, Inc. (IBIO) 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on November 23, 2012, reporting an event that occurred on November 21, 2012. iBio, Inc., a Delaware corporation, received notice from NYSE MKT LLC regarding its failure to meet continued listing standards.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or debt figures. However, it references the Company's Form 10-Q for the period ended September 30, 2012, which indicates:
- Stockholders' equity is less than $6,000,000.
- The Company has reported net losses in its five most recent fiscal years.
Material Changes and Listing Status
The primary material event is the notice of non-compliance with NYSE MKT Section 1003(a)(ii). This standard applies to companies with stockholders' equity below $6,000,000 and net losses over the last five fiscal years. The Company is currently subject to potential delisting procedures if compliance is not restored.
Outlook, Management Commentary, and Risks
Management believes it can submit a satisfactory plan of compliance to the Exchange by December 21, 2012. The proposed plan aims to demonstrate a return to compliance with Section 1003(a)(ii) by October 14, 2013. If the Company fails to submit a plan or if the plan is rejected, it will face delisting. A press release regarding this notice was issued on November 23, 2012.
Investor Verification Checklist
- Verify the specific stockholders' equity and net loss figures in the Form 10-Q for the period ended September 30, 2012.
- Monitor the submission of the compliance plan by the December 21, 2012 deadline.
- Track the Exchange's acceptance or rejection of the compliance plan.
- Review the attached press release (Exhibit 99.1) for additional management commentary.